Skip to main content

Table 1 Baseline characteristics

From: Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)

Characteristics

Intervention Group

n = 90

Control

Group

n = 165

Age, mean ± SD (years)

68.2 (± 9.7)

68.1 (± 10.8)

   Min

45

23

   Max

85

85

Sex, n (%)

  

   female

35 (38.9%)

58 (35.2%)

   male

55 (61.1%)

107 (64.8%)

subtype of cerebral ischemia, n (%)

  

   TIA

28 (31.1%)

49 (29.7%)

   Ischemic stroke

62 (68.9%)

116 (70.3%)

Barthel Index, mean ± SD

92,8 (± 7,5)

89,4 (± 14,3)

cardiovascular risk factors

  

   hypertension

33 (36.7%)

61 (37.0%)

   hyperlipidemia

6 (6.7%)

5 (3.0%)

   diabetes mellitus

1 (1.1%)

2 (1.2%)

   hypertension+hyperlipidemia

31 (34.4%)

46 (27.9%)

   hypertension+diabetes mellitus

4 (4.4%)

20 (12.1%)

   diabetes mellitus+hyperlipidemia

--

2 (1.2%)

   hypertension+diabetes

  

   mellitus+hyperlipidemia

7 (7.8%)

15 (9.1%)

   None

8 (8.9%)

14 (8.5%)

  1. SD = Standard deviation